Vantive, a company that provides vital organ therapies, announced it will invest more than $1 billion over the next five years to drive innovation of digitally-enabled therapies aimed at enhancing access to care, the patient experience and patient outcomes.
In addition, the company stated that its investment in research and development as well as manufacturing capacity is aimed at accelerating the rate of innovation.
Through the development of digitally-enabled dialysis and critical care products and services, Vantive aims to empower earlier and more informed clinical decision-making, thereby reducing disruptions to patient care.
The company also plans to shift kidney care management from an episodic to a proactive approach, with the expectation of enhancing connectivity among the patient care team.
The digital offerings and services include:
Remote patient management: The Sharesource Connectivity Platform is a two-way remote patient management platform that enables patients to use at-home automated peritoneal dialysis and stay connected with their care teams during treatment.
Remote patient management clinical studies: Investigate the implementation of Sharesource Analytics 1.0 in peritoneal dialysis (PD) services and the potential impact of remote patient management tools on the efficiency and clinical outcomes of a PD care team.
Digital health solutions for ICU healthcare practitioners: Vantive’s PrisMax System addresses the urgent challenges faced by ICU healthcare practitioners in treating seriously ill patients.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
